Mesoblast (MESO) Other Non-Current Assets (2015 - 2025)

Mesoblast (MESO) posted quarterly Other Non-Current Assets of $1.2 million for Q4 2025, down 10.43% year-on-year from $1.3 million in Q4 2024, and down 7.87% on a QoQ basis from $1.3 million in Q2 2025.

Mesoblast (MESO) Other Non-Current Assets (2015 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Other Non-Current Assets for 11 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets fell 10.43% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 10.43% YoY) and the FY2025 annual result came in at $1.3 million, down 38.34% from the prior year.
  • Other Non-Current Assets declined to $1.2 million in Q4 2025 per MESO's latest filing, from $1.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MESO reached as high as $3.2 million in Q1 2021 and fell as low as $1.2 million in Q4 2025.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Other Non-Current Assets tumbled 47.93% — and 2023, when it rose 21.03%.
  • Year by year, Other Non-Current Assets stood at $2.0 million in 2021, then retreated by 1.74% to $1.9 million in 2022, then climbed by 16.6% to $2.2 million in 2023, then slumped by 40.52% to $1.3 million in 2024, then declined by 10.43% to $1.2 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.2 million, $1.3 million, and $1.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - 1.19 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.19 Mn
Jun 30, 2025 1.30 Mn
Dec 31, 2024 1.33 Mn
Jun 30, 2024 2.10 Mn
Dec 31, 2023 2.24 Mn
Jun 30, 2023 2.33 Mn
Mar 31, 2023 2.39 Mn
Dec 31, 2022 1.92 Mn
Sep 30, 2022 1.90 Mn
Jun 30, 2022 1.93 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 1.96 Mn
Sep 30, 2021 1.95 Mn
Jun 30, 2021 1.72 Mn
Mar 31, 2021 3.20 Mn
Dec 31, 2020 3.21 Mn
Sep 30, 2020 3.33 Mn
Jun 30, 2020 3.31 Mn
Mar 31, 2020 3.24 Mn
Dec 31, 2019 3.32 Mn